Pharma Journalist - Page 838 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Celgene and Juno Therapeutics sign definitive merger agreement

Seattle Genetics asserted EC’s extension of marketing authorization for ADCETRIS

Enzo Biochem testifies Cervical Cancer Biomarker detection test

FDA approves Ready-to-Use Cardiovascular Medication Bivalirudin for Baxter

FDA offers supplementary clearances to Bio-Rad’s IH-System Gel Reagents, Blood Typing Products

FDA extends Orphan Drug Designation to Enzychem Lifesciences’s EC-18 for treatment of ARS

Astellas Pharma and Vical asserts negative Phase 3 Clinical Trial results for ASP0113 for CMV-HSCT recipients

Agenus launches its Clinical Trial combination of its anti-CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies